Moderna/Merck begins late-stage study of skin cancer vaccine combination, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Data from a mid-stage study had shown that the combination cut the risk of recurrence or death of melanoma, the most deadly form of skin cancer, by 44per cent when compared with Keytruda alone., Data from a mid-stage study had shown that the combination cut the risk of recurrence or death of melanoma, the most deadly form of skin cancer, by 44per cent when compared with Keytruda alone., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *